Trial Details
COMPLETEDBasic Information
| Clinical ID | c220 |
|---|---|
| Identifier | NCT04959851 |
| Trial Title | A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Colitis, Ulcerative|Crohns Disease |
| Interventions | - |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Antwerpen |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2021-12-02 |
|---|---|
| Primary Completion Date | 2024-06-18 |
| Completion Date | 2024-06-18 |